Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Cyclacel Pharmaceuticals, Inc.
(Exact name of Registrant as Specified in its Charter)
Table 1 — Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule (3) | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
| Equity | Common stock, par value $0.001 per share | 457(c) | 411,969 | $2.156 | $888,205.17 | $0.00014760 | $131.10 |
| Total Offering Amount | $888,205.17 | $131.10 | |||||
| Total Fees Previously Paid | — | ||||||
| Total Fee Offsets | — | ||||||
| Net Fee Due | $131.10 | ||||||
| (1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of Cyclacel Pharmaceuticals, Inc. (the “Registrant”) that become issuable with respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of outstanding shares of Registrant’s common stock. |
| (2) | Estimated in accordance with Rules 457(c) solely for purposes of calculating the registration fee on the basis of $2.156, the weighted average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on January 17, 2024. |
| (3) | Consists of 411,969 shares of common stock registered for resale by the selling security holders named in this Registration Statement, issuable upon the exercise of outstanding warrants. |
